cbdMD

YCBD

Market cap $9.69M

CHARLOTTE, N.C., Jan. 14, 2026 /PRNewswire/ -- cbdMD, Inc (NYSE American: YCBD), a leading innovator in hemp-derived wellness products, announced today the closing of the acquisition of substantially all of the assets of Bluebird Botanicals, one of the longest-standing brands in the CBD industry, providing an established and complementary revenue base to strengthen cbdMD's long-term growth strategy.

cbdMD, Inc. (YCBD) Q4 2025 Earnings Call Transcript

CHARLOTTE, N.C. , Dec. 19, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with hemp derived THC beverage line Herbal Oasis today announced our financial results for the full fiscal year ended September 30, 2025.

CHARLOTTE, N.C. , Dec. 19, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), a leading wellness company and the parent of Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, today announces that it has entered into securities purchase agreements with institutional investors whereby Company issued the investors an aggregate of 1,000,000 shares of Series C Convertible Preferred Stock in consideration of gross proceeds to the Company of $2.25 million.

CHARLOTTE, N.C. , Dec. 17, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m.

CHARLOTTE, N.C. , Dec. 8, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), a leading innovator in wellness and hemp-derived products, is pleased to announce that it has regained full compliance with the continued listing standards of the NYSE American.

Year Over Year Net Sales Expected to Remain in line with Prior Year Year Over Year Quarterly Net Sales Expected to Increase Between 3% and 5% CHARLOTTE, N.C. , Nov. 21, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD) (the "Company") one of the most trusted and recognized cannabidiol (CBD) brands in the United States with a comprehensive line of domestically produced CBD products and Farm Bill-compliant Delta-9 offerings, today reported the following preliminary financial results for the fourth quarter of fiscal 2025 and the year ended September 30, 2025.

CHARLOTTE, NC / ACCESS Newswire / October 22, 2025 / cbdMD, Inc. (NYSE American:YCBD), one of the most trusted and recognized cannabidiol (CBD) brands in the United States with a comprehensive line of domestically produced CBD products and Farm Bill-compliant Delta-9 offerings, today announced the addition of two new 10mg flavors to its Herbal Oasis hemp-derived THC-infused social seltzer lineup: Berry Fusion and Tropic Wave. These launches reflect Oasis's strategic focus on data driven product development.

CHARLOTTE, N.C. , Oct. 9, 2025 /PRNewswire/ -- cbdMD , Inc. (NYSE American: YCBD), one of the most trusted and recognized cannabidiol (CBD) brands in the United States with a comprehensive line of domestically produced CBD products and Farm Bill–compliant Delta-9 offerings, today announced that its Herbal Oasis hemp-derived THC-infused social seltzer, designed to redefine how people connect, unwind, and celebrate life, has expanded distribution throughout most of Florida through a new partnership with Bevtalk Distribution, a leading distributor specializing in innovative beverage brands.

Charlotte, North Carolina--(Newsfile Corp. - October 1, 2025) - cbdMD, Inc. (NYSE American: YCBD), a leading wellness company and the parent of Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, today announces that it has entered into a securities purchase agreement with institutional investors including C/M Capital Master Fund, LP (the "Investors") whereby Company issued the Investors a Series B Convertible Preferred Stock (the "Shares") in consideration of gross proceeds to the Company of $1.7 million. The Company intends to use the net proceeds of $1.5 million for working capital general corporate purposes and support ongoing strategic initiatives.